Compound Detail
CHEMBL134713
GTS-21 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL134713 |
| Name | GTS-21 |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | RPYWXZCFYPVCNQ-RVDMUPIBSA-N |
9
Targets
19
Activities
3
Assay Types
3
PK Parameters
20
Publications
4
Known Names
7
Indications
1
Mechanisms
Molecular Properties
308.4
MW (Da)
3.77
ALogP
4
HBA
0
HBD
43.7
PSA (Ų)
0.86
QED
0
Ro5 Violations
4
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Achiral |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| Neuronal acetylcholine receptor protein alpha-7 subunit agonist | AGONIST | Neuronal acetylcholine receptor subunit alpha-7 | ✓ | ✓ |
Indications
Alzheimer Disease Psychotic Disorders Schizophrenia Tobacco Use Disorder Autistic Disorder Mental Disorders Obesity
Activity Summary
Ki 12 meas. best 7.29
Kd 4 meas. best 7.72
EC50 3 meas. best 5.7
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Acetylcholine-binding protein CHEMBL6084 | Kd | 7.72 | 7.72 | 19.0 | 1 |
| Neuronal acetylcholine receptor; alpha4/beta2 CHEMBL1907589 | Ki | 7.29 | 7.29 | 51.0 | 1 |
| Neuronal acetylcholine receptor; alpha4/beta2 CHEMBL1907596 | Ki | 7.29 | 6.99 | 51.0 | 3 |
| Unchecked CHEMBL612545 | Kd | 7.23 | 6.855 | 59.0 | 2 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL4980 | Ki | 6.89 | 6.48 | 130.0 | 3 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL2492 | Kd | 6.8 | 6.8 | 158.0 | 1 |
| Unchecked CHEMBL612545 | Ki | 5.89 | 5.89 | 1300.0 | 1 |
| Neuronal acetylcholine receptor subunit alpha-7 CHEMBL2492 | EC50 | 5.7 | 5.46 | 1995.3 | 2 |
| Neuronal acetylcholine receptor; alpha3/beta4 CHEMBL1907594 | Ki | 5.6 | 5.6 | 2500.0 | 2 |
| Acetylcholine receptor; alpha1/beta1/delta/gamma CHEMBL1907588 | Ki | 5.41 | 5.41 | 3900.0 | 2 |
| Rattus norvegicus CHEMBL376 | EC50 | 5.0 | 5.0 | 10000.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 453.0 | ng.hr.mL-1 | Rattus norvegicus |
| Cmax | 447.5 | nM | Rattus norvegicus |
| T1/2 | 0.47 | hr | Rattus norvegicus |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
| PubMed | DOI | Target Context | # Activities |
|---|---|---|---|
| 35576655 | 10.1016/j.bmc.2022.116811 | RAW264.7 | 8 |
| 15801858 | 10.1021/jm049188d | ADMET | 5 |
| - | 10.6019/CHEMBL4495565 | SARS-CoV-2 | 4 |
| - | 10.6019/CHEMBL4495564 | Replicase polyprotein 1ab | 2 |
| - | 10.6019/CHEMBL4808148 | Histone deacetylase 6 | 2 |
| 16033252 | 10.1021/jm040219e | Neuronal acetylcholine receptor; alpha4/beta2 | 2 |
| 21986237 | 10.1016/j.ejmech.2011.09.033 | Unchecked | 2 |
| 16033252 | 10.1021/jm040219e | Neuronal acetylcholine receptor subunit alpha-7 | 2 |
| 9435889 | 10.1021/jm970377o | Neuronal acetylcholine receptor; alpha4/beta2 | 2 |
| 19208472 | 10.1016/j.bmcl.2009.01.073 | Neuronal acetylcholine receptor subunit alpha-7 | 2 |
| - | 10.6019/CHEMBL4651402 | SARS-CoV-2 | 2 |
| 20236734 | 10.1016/j.ejmech.2010.02.027 | Neuronal acetylcholine receptor subunit alpha-7 | 2 |
| 20236734 | 10.1016/j.ejmech.2010.02.027 | Neuronal acetylcholine receptor; alpha4/beta2 | 2 |
| 15801858 | 10.1021/jm049188d | Unchecked | 1 |
| 21986237 | 10.1016/j.ejmech.2011.09.033 | Neuronal acetylcholine receptor subunit alpha-7 | 1 |
| 21986237 | 10.1016/j.ejmech.2011.09.033 | Acetylcholine-binding protein | 1 |
| 15801858 | 10.1021/jm049188d | Neuronal acetylcholine receptor subunit alpha-7 | 1 |
| 16033252 | 10.1021/jm040219e | Neuronal acetylcholine receptor; alpha4/beta4 | 1 |
| 16033252 | 10.1021/jm040219e | Neuronal acetylcholine receptor; alpha3/beta4 | 1 |
| 9435889 | 10.1021/jm970377o | Rattus norvegicus | 1 |
Data from ChEMBL 36 via Core Engine